LONG BEACH, Calif.–(BUSINESS WIRE)–The Beauty Health Company (“BeautyHealth” or the “Company”; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacialTM, today announced the appointment of Kellie Sears as Chief Human Resources Officer, effective immediately.
Ms. Sears is an accomplished human resources strategist with extensive global experience and a record of transformational leadership supporting rapidly-growing companies. In this role, Ms. Sears will oversee all aspects of human capital management, including talent management, talent acquisition, employee engagement, diversity and inclusion, compensation and benefits and organizational development.
“We are thrilled to have Kellie join us in this important chapter of our growth, as we continue to expand our human capital strategy, enhance global talent capabilities and position the brand for continued success,” said Brent Saunders, Executive Chairman and Interim Chief Executive Officer of BeautyHealth. “Kellie’s knowledge of the beauty health category, and her strong expertise in managing high growth brands will be a great asset as we look to strengthen our global workforce and internal presence.”
Prior to joining BeautyHealth, Ms. Sears held multiple Chief Human Resources Officer roles at both Asklepios BioPharmaceuticals, a leading, clinical-stage gene therapy company, and Allergan plc. She also served in Human Resources leadership roles at Actavis, Forest Laboratories Inc, Pfizer and Pharmacia.
“BeautyHealth has an incredibly strong employee-base with a generous opportunity to expand its roster of talented personnel,” said Ms. Sears. “The Company’s unique infrastructure and successful inhouse capabilities further exemplify its strong attention to its employees, and I look forward to working alongside the team to continue cultivating and recruiting exceptional employees.”
About The Beauty Health Company
BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Our flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator, HydraFacial uses a unique delivery system to cleanse, extract, and hydrate with our patented hydradermabrasion technology and super serums that are made with nourishing ingredients, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. HydraFacial® and Perk™ products are available in over 87 countries with over 19,000 Delivery Systems globally and millions of treatments performed each year. For more information, visit the brand on LinkedIn, Facebook, Instagram, or at HydraFacial.com. For more information, please visit at https://investors.beautyhealth.com/.
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside The Beauty Health Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.
Important factors, among others, that may affect actual results or outcomes include the inability to recognize the anticipated benefits of the Business Combination; costs related to the Business Combination; the inability to maintain the listing of The Beauty Health Company’s shares on Nasdaq; The Beauty Health Company’s ability to manage growth; The Beauty Health Company’s ability to execute its business plan; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; the possibility that The Beauty Health Company may be adversely affected by other economic, business, and/or competitive factors; and the impact of the continuing COVID-19 pandemic on the Company’s business. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.